Combination treatment of tamoxifen with risperidone in breast cancer.
Tamoxifen has long been used and still is the most commonly used endocrine therapy for treatment of both early and advanced estrogen receptor-positive breast cancer in pre- and post-menopause women. Tamoxifen exerts its cytotoxic effect primarily through cytostasis which is associated with the accum...
Saved in:
Main Authors: | Wei-Lan Yeh, Hui-Yi Lin, Hung-Ming Wu, Dar-Ren Chen |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/34c75769992945b38a66644ca816fce3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Disruption of the ER-α36-EGFR/HER2 positive regulatory loops restores tamoxifen sensitivity in tamoxifen resistance breast cancer cells.
by: Li Yin, et al.
Published: (2014) -
Tamoxifen for women at high risk of breast cancer
by: Nazarali SA, et al.
Published: (2014) -
Preparation and characterization of Tamoxifen citrate loaded nanoparticles for breast cancer therapy
by: Maji R, et al.
Published: (2014) -
Breast Cancer and Tamoxifen: A Nigerian Perspective to Effective Personalised Therapy
by: Adehin A, et al.
Published: (2020) -
Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
by: Zhao Y, et al.
Published: (2013)